354 related articles for article (PubMed ID: 2462608)
1. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.
Sthoeger ZM; Wakai M; Tse DB; Vinciguerra VP; Allen SL; Budman DR; Lichtman SM; Schulman P; Weiselberg LR; Chiorazzi N
J Exp Med; 1989 Jan; 169(1):255-68. PubMed ID: 2462608
[TBL] [Abstract][Full Text] [Related]
2. Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies.
Bröker BM; Klajman A; Youinou P; Jouquan J; Worman CP; Murphy J; Mackenzie L; Quartey-Papafio R; Blaschek M; Collins P
J Autoimmun; 1988 Oct; 1(5):469-81. PubMed ID: 2473761
[TBL] [Abstract][Full Text] [Related]
3. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing.
Wakai M; Hashimoto S; Omata M; Sthoeger ZM; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Diamond B; Dono M
Autoimmunity; 1994; 19(1):39-48. PubMed ID: 7538331
[TBL] [Abstract][Full Text] [Related]
4. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemia.
Sthoeger ZM; Sthoeger D; Shtalrid M; Sigler E; Geltner D; Berrebi A
Am J Hematol; 1993 Aug; 43(4):259-64. PubMed ID: 7690517
[TBL] [Abstract][Full Text] [Related]
6. Malignant CD5 B cells--biased immunoglobulin variable gene usage and autoantibody production.
Mayer R; Stone K; Han A; Bona C
Int Rev Immunol; 1991; 7(3):189-203. PubMed ID: 1721931
[TBL] [Abstract][Full Text] [Related]
7. Evidence for somatic selection of natural autoantibodies.
Martin T; Duffy SF; Carson DA; Kipps TJ
J Exp Med; 1992 Apr; 175(4):983-91. PubMed ID: 1552291
[TBL] [Abstract][Full Text] [Related]
8. Modulation and high frequency expression of autoantibody-associated cross-reactive idiotypes linked to the VHI subgroup in CD5-expressing B lymphocytes from patients with chronic lymphocytic leukaemia (B-CLL).
Shokri F; Mageed RA; Richardson P; Jefferis R
Scand J Immunol; 1993 Jun; 37(6):673-9. PubMed ID: 7686301
[TBL] [Abstract][Full Text] [Related]
9. CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies.
Kipps TJ; Robbins BA; Tefferi A; Meisenholder G; Banks PM; Carson DA
Am J Pathol; 1990 Apr; 136(4):809-16. PubMed ID: 1691593
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin V gene utilization in chronic lymphocytic leukemia and non-Hodgkin's B cell lymphomas.
Kipps TJ
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):293-8. PubMed ID: 3065730
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin V gene expression in CD5 B-cell malignancies.
Kipps TJ; Rassenti LZ; Duffy S; Johnson T; Kobayashi R; Carson DA
Ann N Y Acad Sci; 1992 May; 651():373-83. PubMed ID: 1376056
[TBL] [Abstract][Full Text] [Related]
12. The importance of CD5-positive B cells in nonorgan-specific autoimmune diseases.
Youinou P; Mackenzie L; Broker BM; Isenberg DI; Drogou-Lelong A; Gentric A; Lydyard PM
Scand J Rheumatol Suppl; 1988; 76():243-9. PubMed ID: 2471999
[TBL] [Abstract][Full Text] [Related]
13. Uniform high frequency expression of autoantibody-associated crossreactive idiotypes in the primary B cell follicles of human fetal spleen.
Kipps TJ; Robbins BA; Carson DA
J Exp Med; 1990 Jan; 171(1):189-96. PubMed ID: 1688607
[TBL] [Abstract][Full Text] [Related]
14. Anti-DNA antibody production by CD5+ and CD5- B cells of patients with systemic lupus erythematosus.
Suzuki N; Sakane T; Engleman EG
J Clin Invest; 1990 Jan; 85(1):238-47. PubMed ID: 1688569
[TBL] [Abstract][Full Text] [Related]
15. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies.
Borche L; Lim A; Binet JL; Dighiero G
Blood; 1990 Aug; 76(3):562-9. PubMed ID: 2378986
[TBL] [Abstract][Full Text] [Related]
16. Human hybridomas derived from CD5+ B lymphocytes of patients with chronic lymphocytic leukemia (B-CLL) produce multi-specific natural IgM (kappa) antibodies.
Jahn S; Schwab J; Hansen A; Heider H; Schroeder C; Lukowsky A; Achtman M; Matthes H; Kiessig ST; Volk HD
Clin Exp Immunol; 1991 Mar; 83(3):413-7. PubMed ID: 1706236
[TBL] [Abstract][Full Text] [Related]
17. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
Rassenti LZ; Kipps TJ
J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
[TBL] [Abstract][Full Text] [Related]
18. The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation.
Lee KW; Inghirami G; Spatz L; Knowles DM; Latov N
J Neuroimmunol; 1991 Jan; 31(1):83-8. PubMed ID: 1701449
[TBL] [Abstract][Full Text] [Related]
19. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy.
Kipps TJ; Tomhave E; Chen PP; Carson DA
J Exp Med; 1988 Mar; 167(3):840-52. PubMed ID: 3127527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
